HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L’Oréal Q1

This article was originally published in The Rose Sheet

Executive Summary

First quarter sales increased 10.4% to $3.96 bil. (€1=$1.08) at comparable structure and constant exchange rates, French firm states April 3. Currency had substantial negative impact of 11.7% on sales. Consolidated sales compared with the year-ago period were down 1.1%. Professional product division sales increased 9.8%, consumer product revenue advanced 14.2%, luxury products rose 2.5% and active cosmetics division sales gained 11.2%, L'Oréal says...

You may also be interested in...



Medtronic Brain Imaging Software Recalled After 11 Injuries

The Minnesota-based medtech giant has had to yank a software used on its SealthStation platforms used to help surgeons navigate a patient’s brain during surgery. However, minor movements by the patient have been found to give false imaging that could endanger the patient’s life.

European CHMP Opinions and MAA Updates

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.

SwedenBio Snapshot Shows Vibrant Ecosystem

Sweden´s ecosystem for drug discovery and development is flourishing, seeded by academia, nurtured by incubators and funded from varied sources, 2020 report shows.

UsernamePublicRestriction

Register

LL1132521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel